About   Help   FAQ
Mammalian Phenotype Ontology Annotations
Query Results - Summary
Symbol
Name
ID
Olig2
oligodendrocyte transcription factor 2
MGI:1355331
70 phenotypes from multigenic genotypes
Export: Excel File
Allelic Composition
Genetic Background
Annotated Term Reference
Acvr1tm1Mak/Acvr1+
Gt(ROSA)26Sortm9(CAG-tdTomato)Hze/Gt(ROSA)26Sor+
Olig2tm1.1(cre)Wdr/Olig2+
involves: 129 * C57BL/6
increased oligodendrocyte number J:285841
Acvr1tm1Mak/Acvr1+
Olig2tm1.1(cre)Wdr/Olig2+
involves: 129P2/OlaHsd * 129S1/Sv * 129X1/SvJ * C57BL/6
abnormal brain development J:285841
abnormal brainstem morphology J:285841
abnormal glial cell physiology J:285841
ataxia J:285841
muscle spasm J:285841
normal neoplasm J:285841
preweaning lethality, incomplete penetrance J:285841
Acvr1tm1Mak/Acvr1+
Gt(ROSA)26Sortm1(Pik3ca*H1047R)Egan/Gt(ROSA)26Sor+
Olig2tm1.1(cre)Wdr/Olig2+
involves: 129 * C57BL/6 * FVB/N
increased brain tumor incidence J:285841
increased glioma incidence J:285841
Acvr1tm1Mak/Acvr1+
Gt(ROSA)26Sortm1(Pik3ca*H1047R)Egan/Gt(ROSA)26Sor+
H3c2tm1Mak/H3c2+
Olig2tm1.1(cre)Wdr/Olig2+
involves: 129 * C57BL/6 * FVB/N
increased brain tumor incidence J:285841
increased glioma incidence J:285841
Acvr1tm1Mak/Acvr1+
H3c2tm1Mak/H3c2+
Olig2tm1.1(cre)Wdr/Olig2+
involves: 129P2/OlaHsd * 129S1/Sv * 129X1/SvJ * C57BL/6
normal neoplasm J:285841
postnatal lethality, incomplete penetrance J:285841
Cdh2tm1Glr/Cdh2tm1Glr
Olig2tm1(cre)Tmj/Olig2+
involves: 129S6/SvEvTac
abnormal neuronal migration J:178688
abnormal spinal cord morphology J:178688
abnormal spinal cord motor column morphology J:178688
lethality throughout fetal growth and development, incomplete penetrance J:178688
neonatal lethality, complete penetrance J:178688
Cspg4tm1Ychan/Cspg4tm1Ychan
Olig2tm2(TVA,cre)Rth/Olig2+
involves: 129 * C57BL/6N
decreased body weight J:184220
decreased epididymal fat pad weight J:184220
Ctnnb1tm2Kem/Ctnnb1tm2Kem
Juptm1Ruiz/Juptm1.1Tmj
Olig2tm1(cre)Tmj/Olig2+
involves: 129P2/OlaHsd * 129S1/Sv * 129X1/SvJ
abnormal dendrite morphology J:178688
lethality throughout fetal growth and development, complete penetrance J:178688
Ctnnb1tm2Kem/Ctnnb1tm2Kem
Juptm1Ruiz/Juptm1Ruiz
Olig2tm1(cre)Tmj/Olig2+
involves: 129P2/OlaHsd * 129S1/Sv * 129X1/SvJ
abnormal neuronal migration J:178688
abnormal spinal cord lateral motor column morphology J:178688
abnormal spinal cord medial motor column morphology J:178688
abnormal spinal cord motor column morphology J:178688
abnormal ventral interneuron 1 morphology J:178688
abnormal ventral interneuron 2 morphology J:178688
decreased motor neuron number J:178688
embryonic lethality during organogenesis, complete penetrance J:178688
normal nervous system phenotype J:178688
Ctnnb1tm2Kem/Ctnnb1tm2Kem
Olig2tm1(cre)Tmj/Olig2+
involves: 129S1/Sv * 129X1/SvJ
abnormal spinal cord medial motor column morphology J:178688
decreased motor neuron number J:178688
neonatal lethality, complete penetrance J:178688
Gt(ROSA)26Sorem2(Mios)Bcgen/Gt(ROSA)26Sor+
Miostm1Pfw/Miostm1Pfw
Olig2tm2(TVA,cre)Rth/Olig2+
involves: 129 * C57BL/6
normal nervous system phenotype J:320720
Gt(ROSA)26Sortm1(Hoxa2)Fmr/Gt(ROSA)26Sor+
Olig2tm2(TVA,cre)Rth/Olig2+
involves: 129P2/OlaHsd
abnormal brain development J:193058
decreased oligodendrocyte progenitor number J:193058
Gt(ROSA)26Sortm1(Pik3ca*H1047R)Egan/Gt(ROSA)26Sor+
Olig2tm1.1(cre)Wdr/Olig2+
involves: 129 * C57BL/6 * FVB/N
normal neoplasm J:285841
Gt(ROSA)26Sortm1(Pik3ca*H1047R)Egan/Gt(ROSA)26Sor+
H3c2tm1Mak/H3c2+
Olig2tm1.1(cre)Wdr/Olig2+
involves: 129 * C57BL/6 * FVB/N
normal neoplasm J:285841
Gt(ROSA)26Sortm1(Smo/EYFP)Amc/Gt(ROSA)26Sortm1(Smo/EYFP)Amc
Olig2tm2(TVA,cre)Rth/Olig2+
involves: 129 * 129X1/SvJ
increased medulloblastoma incidence J:139574
premature death J:139574
Mapttm1(Sema3e)Yuyo/Mapt+
Olig2tm1(cre)Tmj/Olig2+
Not Specified
abnormal excitatory postsynaptic potential J:205528
abnormal sensory neuron innervation pattern J:205528
abnormal synaptic bouton morphology J:205528
normal nervous system phenotype J:205528
Miostm1Pfw/Miostm1Pfw
Olig2tm2(TVA,cre)Rth/Olig2+
involves: 129 * C57BL/6
abnormal oligodendrocyte physiology J:320720
normal behavior/neurological phenotype J:320720
decreased oligodendrocyte number J:320720
dysmyelination J:320720
Myrftm1Barr/Myrftm1Barr
Olig2tm2(TVA,cre)Rth/Olig2+
involves: 129P2/OlaHsd * 129S4/SvJaeSor * C57BL/6
abnormal myelination J:150563
abnormal optic nerve morphology J:150563
abnormal spinal cord morphology J:150563
ataxia J:150563
normal nervous system phenotype J:150563
postnatal lethality, complete penetrance J:150563
seizures J:150563
tremors J:150563
Ntf3tm2.1Jae/Ntf3tm2Jae
Olig2tm2(cre)Htak/Olig2+
Not Specified
abnormal dorsal root ganglion morphology J:182750
abnormal proprioceptive neuron morphology J:182750
abnormal sensory neuron innervation pattern J:182750
Olig1tm1And/Olig1tm1And
Olig2tm1And/Olig2tm1And
involves: 129 * C57BL/6J
abnormal nervous system development J:76446
abnormal ventral interneuron 2 morphology J:76446
absent oligodendrocytes J:76446
decreased fetal size J:76446
decreased motor neuron number J:76446
decreased oligodendrocyte progenitor number J:76446
perinatal lethality, complete penetrance J:76446
Olig1tm1And/Olig1tm1And
Olig2tm1And/Olig2tm1And
Tg(Olig2)#Wdr/?
Not Specified
abnormal oligodendrocyte morphology J:210099
Olig2tm1(cre)Tmj/Olig2+
Shhtm2Amc/Shhtm2Amc
involves: 129S1/Sv * 129X1/SvJ
abnormal spinal cord lateral motor column morphology J:277700
decreased motor neuron number J:277700
normal nervous system phenotype J:277700
Olig2tm1(cre)Tmj/Olig2+
Smn1tm1Jme/Smn1tm1Msd
Grm7Tg(SMN2)89Ahmb/Grm7+
involves: 129 * 129P2/OlaHsd * FVB/N
postnatal lethality, complete penetrance J:164292
Olig2tm1(cre)Tmj/Olig2+
Smn1tm1Jme/Smn1tm1Msd
Grm7Tg(SMN2)89Ahmb/Grm7Tg(SMN2)89Ahmb
involves: 129 * 129P2/OlaHsd * FVB/N
abnormal CNS synaptic transmission J:164292
abnormal miniature endplate potential J:164292
abnormal muscle morphology J:164292
abnormal neuromuscular synapse morphology J:164292
abnormal PNS synaptic transmission J:164292
abnormal sensory neuron innervation pattern J:164292
abnormal synaptic bouton morphology J:164292
abnormal synaptic transmission J:164292
decreased body weight J:164292
decreased grip strength J:164292
decreased skeletal muscle fiber number J:164292
decreased survivor rate J:164292
increased skeletal muscle fiber size J:164292
kyphosis J:164292
motor neuron degeneration J:164292
muscle weakness J:164292
muscular atrophy J:164292
premature death J:164292
skeletal muscle fiber degeneration J:164292
Prrc2atm1Fcw/Prrc2atm1Fcw
Olig2tm2(TVA,cre)Rth/Olig2+
involves: 129 * C57BL/6
abnormal brain morphology J:301796
abnormal corpus callosum morphology J:301796
decreased body weight J:301796
decreased grip strength J:301796
decreased oligodendrocyte number J:301796
decreased oligodendrocyte progenitor number J:301796
dysmyelination J:301796
enlarged lateral ventricles J:301796
impaired coordination J:301796
impaired spatial learning J:301796
increased brain weight J:301796
normal nervous system phenotype J:301796
premature death J:301796

Contributing Projects:
Mouse Genome Database (MGD), Gene Expression Database (GXD), Mouse Models of Human Cancer database (MMHCdb) (formerly Mouse Tumor Biology (MTB)), Gene Ontology (GO)
Citing These Resources
Funding Information
Warranty Disclaimer, Privacy Notice, Licensing, & Copyright
Send questions and comments to User Support.
last database update
11/12/2024
MGI 6.24
The Jackson Laboratory